TD Cowen Sticks to Their Hold Rating for Milestone Pharmaceuticals (MIST)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Baral is a 3-star analyst with an average return of 2.5% and a 39.31% success rate. Baral covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, Alnylam Pharma, and Madrigal Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Milestone Pharmaceuticals with a $7.50 average price target.
MIST market cap is currently $65.23M and has a P/E ratio of -1.47.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
36 minutes ago
- Business Insider
Mixed options sentiment in Pinduoduo with shares down 0.41%
Mixed options sentiment in Pinduoduo (PDD), with shares down 42c near $103.55. Options volume relatively light with 18k contracts traded and calls leading puts for a put/call ratio of 0.83, compared to a typical level near 1.5. Implied volatility (IV30) dropped 1.23 near 32.43,in the lowest 10% of observations over the past year, suggesting an expected daily move of $2.12. Put-call skew flattened, suggesting a modestly bullish tone. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Business Insider
an hour ago
- Business Insider
How Google (GOOGL) Plans to Rebuild Trust with Publishers as AI Reduces Web Traffic
Tech giant Google's (GOOGL) relationship with publishers has become strained as its move toward AI-powered search has reduced the web traffic being sent to content sites. To rebuild trust, Google is making changes to better support publishers, according to The Information. Indeed, teams within Google Ad Manager—the division that helps publishers sell ad space—have begun hiring new staff in order to promote the platform to large advertisers and ad agencies. The plan is to increase premium ad spending on publisher websites, which could boost their revenues. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Interestingly, publishers say that they typically earn less when using Google's ad tools compared to working with competitors like PubMatic (PUBM) and Magnite (MGNI). That's because Google's platform is primarily used by small businesses, which tend to pay less for ads. Meanwhile, companies like PubMatic and Magnite focus more on attracting large advertisers. In addition, one publisher reported a steady drop in revenue from Google's ad tech tools over the last three years, blaming it on Google falling behind rivals. However, in addition to staff changes, Google is launching new products for publishers. One example is Offerwall, a tool that lets readers access articles by either paying directly or watching an ad. This is part of the move to give publishers more ways to make money. It is worth noting that Google had launched a similar product in 2017 called Funding Choices, but it didn't promote it much, so it failed to gain traction. Moreover, Google has recently focused more on DV360, its ad platform that sells ads on YouTube and third-party websites, which is more profitable and faces less legal scrutiny. Is Google Stock a Good Buy? Turning to Wall Street, analysts have a Strong Buy consensus rating on GOOGL stock based on 29 Buys and nine Holds assigned in the past three months. Furthermore, the average GOOGL price target of $199.77 per share implies 11.5% upside potential from current levels.
Business Insider
an hour ago
- Business Insider
Banzai announces one-for-ten reverse stock split
Banzai (BNZI) announced that effective at market open on July 8, the company will effect a one-for-ten reverse stock split of its outstanding Class A Common Stock and Class B Common Stock. The reverse stock split is primarily intended to increase the per share price of Banzai's Class A Common Stock and maintain compliance with the Nasdaq minimum bid price requirement. The company's Class A common stock will continue to trade. Upon the effectiveness of the reverse stock split, every ten shares of issued and outstanding common stock before the open of business on July 8, will be combined into one issued and outstanding share of common stock, with no change in par value per share. The company's Class A common stock will open for trading on Nasdaq on July 8 on a post-split basis but will trade under a new CUSIP Number. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with , delivered to your inbox every week.
